Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (141-150 of 365) with videos related to

Pageof 37
Sort By:
Neurobiology of Aging|January 15, 2015
Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageingRobert H Pietrzak, Yen Ying Lim, David Ames, et al.
The Lancet. Neurology|March 13, 2013
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyVictor L Villemagne, Samantha Burnham, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|May 26, 2012
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal studyNicolas Villain, Gaël Chételat, Blandine Grassiot, et al.
Nuclear Medicine and Biology|July 20, 2005
Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PETSascha Mitkovski, Victor L Villemagne, Kathy E Novakovic, et al.
Plos One|April 5, 2013
Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trialsK Abigail Andrews, Marc Modat, Kate E Macdonald, et al.
Brain : a Journal of Neurology|November 2, 2013
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's diseaseYen Ying Lim, Paul Maruff, Robert H Pietrzak, et al.
Neuro-Degenerative Diseases|January 21, 2012
Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imagingVictor L Villemagne, Nobuyuki Okamura, Svetlana Pejoska, et al.
Alzheimer'S Research & Therapy|January 18, 2013
(18)F-florbetaben Aβ imaging in mild cognitive impairmentKevin Ong, Victor L Villemagne, Alex Bahar-Fuchs, et al.
BMC Genomics|May 26, 2022
Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer's diseaseMichael Vacher, Vincent Doré, Tenielle Porter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172Graeme J O'Keefe, Timothy H Saunder, Steven Ng, et al.
Pageof 37

Showing results (141-150 of 365) with videos related to

Sort By:
Pageof 37
Neurobiology of Aging|January 15, 2015
Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageingRobert H Pietrzak, Yen Ying Lim, David Ames, et al.
The Lancet. Neurology|March 13, 2013
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort studyVictor L Villemagne, Samantha Burnham, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|May 26, 2012
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal studyNicolas Villain, Gaël Chételat, Blandine Grassiot, et al.
Nuclear Medicine and Biology|July 20, 2005
Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PETSascha Mitkovski, Victor L Villemagne, Kathy E Novakovic, et al.
Plos One|April 5, 2013
Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trialsK Abigail Andrews, Marc Modat, Kate E Macdonald, et al.
Brain : a Journal of Neurology|November 2, 2013
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's diseaseYen Ying Lim, Paul Maruff, Robert H Pietrzak, et al.
Neuro-Degenerative Diseases|January 21, 2012
Differential diagnosis in Alzheimer's disease and dementia with Lewy bodies via VMAT2 and amyloid imagingVictor L Villemagne, Nobuyuki Okamura, Svetlana Pejoska, et al.
Alzheimer'S Research & Therapy|January 18, 2013
(18)F-florbetaben Aβ imaging in mild cognitive impairmentKevin Ong, Victor L Villemagne, Alex Bahar-Fuchs, et al.
BMC Genomics|May 26, 2022
Assessment of a polygenic hazard score for the onset of pre-clinical Alzheimer's diseaseMichael Vacher, Vincent Doré, Tenielle Porter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172Graeme J O'Keefe, Timothy H Saunder, Steven Ng, et al.
Pageof 37